Antioxidants offer pain relief to CP patients

12 January 2009

Antioxidant supplementation is effective in relieving pain and reducing levels of oxidative stress in patients with chronic pancreatitis,  according to a new study published in the journal Gastroenterology.

In the placebo-controlled, double-blind trial, 127 patients were  assigned to placebo or antioxidant groups. After six months, the  reduction in the number of painful days per month was significantly  higher in the antioxidant group compared with the placebo group. The  reduction in the number of analgesic tablets per month was also higher  in the antioxidant group. Furthermore, 32% and 13% of patients became  pain free in the antioxidant and placebo groups, respectively; the  beneficial effect of antioxidants on pain relief was noted early at  three months.

"Abdominal pain, the predominant symptom in patients with CP, is  difficult to treat. The main reason for a largely ineffective medical  treatment is that the mechanism of pain in CP is not well understood,"  said lead author Pramod Garg. "We are encouraged by our findings, as  significant improvement was noted with antioxidants in respect to all  the parameters of pain in this study. In addition, reduction in pain  resulted in fewer man-days lost, thus providing functional employment  gain to the patients," he added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Company Spotlight